Search results

Skip to results

Area of interest

Area of interest

Type

Type

Status

Status

Last updated

Last updated

Guidance programme

Advice programme

Showing 5386 to 5400 of 7681 results

  1. Is there a potential for dependence associated with pharmacological agents for neuropathic pain?

    Recommendation ID CG173/6 Question Is there a potential for dependence associated with pharmacological agents for neuropathic pain?

  2. Pizotifen to prevent recurrent migraine:- Is pizotifen a clinically and cost effective prophylactic treatment for recurrent migraine?

    Recommendation ID CG150/2 Question Pizotifen to prevent recurrent migraine:- Is pizotifen a clinically and cost effective prophylactic

  3. Potential for dependence associated with pharmacological drugs for neuropathic pain:- Is there a potential for dependence associated with pharmacological agents for neuropathic pain?

    Recommendation ID CG173/6 Question Potential for dependence associated with pharmacological drugs for neuropathic pain:- Is there a potential

  4. Point-of-care coagulation testing:- What is the clinical and cost effectiveness of point-of-care coagulation testing using rotational thromboelastometry (ROTEM) or thromboelastography (TEG) to target treatment, compared with standard laboratory coagulation testing?

    Recommendation ID NG39/1 Question Point-of-care coagulation testing:- What is the clinical and cost effectiveness of point-of-care coagulation

  5. What is the effectiveness, cost effectiveness and acceptability of social prescribing for carers?

    Recommendation ID NG150/5 Question What is the effectiveness, cost effectiveness and acceptability of social prescribing for carers?

  6. The committee recommended studies to collect data on the rates of cancelled CT scans, whether cancelled appointments are filled and the effect on patients' experience before and after the introduction of point-of-care (POC) creatinine devices to radiology departments.

    Recommendation ID DG37/3 Question The committee recommended studies to collect data on the rates of cancelled CT scans, whether cancelled

  7. What is the effectiveness, cost effectiveness and acceptability of carer passport schemes?

    Recommendation ID NG150/4 Question What is the effectiveness, cost effectiveness and acceptability of carer passport schemes? Any

  8. The committee recommended that a suitable risk factor screening tool for identifying risk of PC‑AKI for use across the NHS in people presenting for an outpatient CT scan with contrast agent is developed or an existing tool is validated.

    Recommendation ID DG37/2 Question The committee recommended that a suitable risk factor screening tool for identifying risk of PC‑AKI for

  9. Predicting life expectancy:- Is it possible to analyse primary care data to identify characteristics that affect life expectancy and to develop algorithms and prediction tools for patients and healthcare providers to predict reduced life expectancy?

    Recommendation ID NG56/4 Question Predicting life expectancy:- Is it possible to analyse primary care data to identify characteristics

  10. The committee recommended further research on the incidence and effect of post-contrast acute kidney injury (PC‑AKI) in people with eGFR less than 30 ml/min/1.73 m2.

    Recommendation ID DG37/1 Question The committee recommended further research on the incidence and effect of post-contrast acute kidney

  11. Prediction tools: What is the effectiveness of prediction tools for identifying women who are at risk of pelvic floor dysfunction?

    Recommendation ID NG210/05 Question Prediction tools: What is the effectiveness of prediction tools for identifying women who are at risk

  12. Polysomnography:- Does preoperative screening of people who are at risk of obstructive sleep apnoea with polysomnography identify those at higher risk of postoperative complications?

    Recommendation ID NG45/1 Question Polysomnography:- Does preoperative screening of people who are at risk of obstructive sleep apnoea with

  13. Priority of treatment for people with anxiety and depression:- For people with both anxiety and depression, which disorder should be treated first to improve their outcomes?

    Recommendation ID CG123/6 Question Priority of treatment for people with anxiety and depression:- For people with both anxiety and depression